Mattia Galli/LinkedIn
Oct 5, 2025, 08:21
Mattia Galli Gives a Talk on Pharma Pulse About “De-escalation” of Antiplatelet Therapy in ACS
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared on LinkedIn:
”How far can we go with the “de-escalation” of antiplatelet therapy in patients with acute coronary syndrome?
We talk about it in our Pharma Pulse following the publication of the NEO-MINDSET trial.”
Read the full article in EHJ.
Article: Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome
Authors: Mattia Galli, Felice Gragnano, Marco Valgimigli
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jul 8, 2026, 21:30Matthew Gouveia: How VNS-REHAB Is Transforming the Future of Stroke Rehabilitation
-
Jul 8, 2026, 21:22What Hundreds of Stroke Stories Have Taught Diana Kerr About Recovery and Resilience – Stroke Foundation
-
Jul 8, 2026, 19:50Heghine Khachatryan: Why the EHC Fully Supports the Lancet Commission on Women’s Hematological Health
-
Jul 8, 2026, 19:40Autoregulation Failure in SVD and Cognitive Impairment – International Journal of Stroke
-
Jul 8, 2026, 19:30Ahmed Mostafa: Why Antibodies Cause Organ Rejection
-
Jul 8, 2026, 19:28Erika Bocanegra: Witnessing 25 Years of Progress in Bleeding Disorders Care
-
Jul 8, 2026, 19:27Ahmadou Ouedraogo: Do You Know Your Blood Type?
-
Jul 8, 2026, 19:26Javed Anees: An Evidence-Based Clinical Guide to ESA Therapy
-
Jul 8, 2026, 19:25Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research